Market Closed -
Other stock markets
|
After market 03:59:57 pm | |||
5.235 EUR | -3.06% | 5.228 | -0.13% |
Apr. 03 | Nanobiotix completes escalation portion of 2020-0123 study | CF |
Apr. 02 | Nanobiotix Completes Dose Escalation Segment of Phase 1 Study Targeting Non-Small Cell Lung Cancer | MT |
- Stock Market
- Equities
- NANO Stock
- News Nanobiotix